BRIEF-Genmab announces new late stage combination study of Daratumumab in multiple myeloma
April 28, 2017 at 09:41 AM EDT
* Genmab announces new phase III combination study of Daratumumab in multiple myeloma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.